To check whether the effect of NRTI on tumor recurrence following chemotherapy is a general phenomenon or is limited to the MMTV-HER2/Neu–17-DMAG model, we used another spontaneous cancer model with a well-characterized response to chemotherapy, the Th-MYCN mouse model (24, 27). Here, ERBB2 is linked to cancer.